Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06680739
Title Single cEll pRofiling PErsistaNce To ImmuNothErapy (SERPENTINE)
Acronym SERPENTINE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Vall d'Hebron Institute of Oncology
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.